Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2024 | 2 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Therapeutic efficacy of FASN inhibition in preclinical models of HCC.
Hepatology. 2022 Oct;76(4):951-966. doi: 10.1002/hep.32359. Epub 2022 Feb 16.
Hepatology. 2022.
PMID: 35076948
Free PMC article.
The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial.
Hsiehchen D, Beg MS, Kainthla R, Lohrey J, Kazmi SM, Khosama L, Maxwell MC, Kline H, Katz C, Hassan A, Kubota N, Siglinsky E, Pillai AK, Youssoufian H, Mockbee C, Culm K, Uhlik M, Benjamin L, Brekken RA, Ahn C, Singal AG, Zhu H, Hoshida Y, Yopp AC.
Hsiehchen D, et al.
Nat Commun. 2024 Mar 11;15(1):2178. doi: 10.1038/s41467-024-46542-y.
Nat Commun. 2024.
PMID: 38467639
Free PMC article.
Clinical Trial.
Item in Clipboard
Primary liver cancer spectrum: current knowledge and the next steps.
Rezaee-Zavareh MS, Koltsova EK, Hoshida Y, Yang JD.
Rezaee-Zavareh MS, et al.
Hepatobiliary Surg Nutr. 2024 Feb 1;13(1):157-160. doi: 10.21037/hbsn-23-607. Epub 2024 Jan 15.
Hepatobiliary Surg Nutr. 2024.
PMID: 38322221
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite